Regenerative Medicine Uncovered for Musculoskeletal Health

Transform your approach to musculoskeletal health with regenerative medicine techniques for improved outcomes.

Abstract

Hello, I’m Dr. Alex Jimenez. In this comprehensive educational post, we will journey into the heart of integrative and regenerative medicine, exploring how cutting-edge cellular therapies, evidence-based chiropractic care, and functional medicine are revolutionizing our approach to chronic pain, tissue injury, and systemic health. From my perspective as a practitioner with a diverse background in chiropractic, nursing, and functional medicine, I will guide you through the intricate science of these therapies. We will delve into the pioneering work of leading researchers and clinicians, like Dr. John Skaravakis and Dr. Michelle Ferguson, to understand the biological processes behind treatments using mesenchymal stem cells (MSCs), secretomes, and exosomes. This exploration will cover the science of the paracrine effect, the profound immunomodulatory and antifibrotic capabilities of these biologics, and why certain sources, such as umbilical cord tissue and even menstrual-derived stem cells, offer unique advantages. We will also investigate often-overlooked conditions like pelvic floor dysfunction and chronic allergies, presenting innovative, non-invasive treatment modalities like high-intensity focused electromagnetic (HIFEM) technology and in-office immunotherapy.

Furthermore, this post will illuminate the synergistic power of our integrative care model at Injury Medical Clinic PA in El Paso, Texas. I will detail how my work as a Doctor of Chiropractic and Advanced Practice Registered Nurse integrates seamlessly with the comprehensive medical oversight of our Medical Director, Dr. Maria Guadalupe Cardenas, MD, an esteemed internist with over 40 years of experience. We will explore how our multidisciplinary team combines advanced therapies with foundational care, including chiropractic adjustments, functional medicine, personalized rehabilitation, and targeted nutrition. This guide showcases how our synergistic approach doesn’t just mask symptoms but targets the root causes of dysfunction, from biomechanical instability and cellular dysfunction to systemic inflammation. Our goal is to provide a comprehensive, easy-to-understand roadmap that illustrates how we can optimize patient outcomes, restore function, and pave a new path toward true, lasting healing and vitality.

Our Collaborative and Integrative Clinical Model

At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we have cultivated a unique and powerful healthcare model built on the principle of integrative and collaborative care. My career has been a relentless pursuit of the most effective, evidence-based methods to help my patients heal and thrive. This journey has given me a diverse background, including credentials as a Doctor of Chiropractic (DC), an Advanced Practice Registered Nurse (APRN), and a board-certified Family Nurse Practitioner (FNP-BC), as well as certifications in Functional Medicine (CFMP, IFMCP), among others. This multidisciplinary training allows me to view patient health through several lenses—structural, functional, systemic, and cellular.

However, the true strength of our practice lies in our multidisciplinary team structure. A cornerstone of this model is our collaboration with Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a highly respected, board-certified internist with over four decades of invaluable experience (NPI #1164426749, Texas MD License #J2933). As our Medical Director and Collaborative Physician, she provides essential medical oversight, manages complex internal medicine issues that can influence recovery, and works in tandem with our team. This integrative setup, where a medical doctor and a chiropractor work side-by-side, is a hallmark of progressive injury and integrative care clinics and is vital for providing comprehensive care, particularly in the realms of personal injury, chronic pain, and complex health conditions.

Together, our team seamlessly integrates a spectrum of services:

• Medical Oversight (Dr. Cardenas): Ensuring all treatment plans are medically sound, safe, and appropriate for each patient’s unique health profile, including managing comorbidities and guiding diagnostic pathways.
• Chiropractic Care (Dr. Jimenez): Focusing on spinal alignment, nervous system function, and musculoskeletal integrity as the foundation of health.
• Functional Medicine: Investigating and addressing the root causes of disease, from hormonal imbalances and gut health to metabolic dysfunction and systemic inflammation.
• Regenerative Medicine: Utilizing the latest in cellular therapies to promote tissue repair and reduce inflammation, always within a framework of evidence and regulatory compliance.
• Advanced Rehabilitation and Personal Injury Care: Designing customized programs to restore function, reduce pain, and help patients recover fully from accidents and injuries.

This integrated model ensures that our patients receive a holistic, well-rounded treatment plan that addresses their health from every possible angle, leading to superior outcomes and a genuine return to wellness. From this integrative vantage point, I wish to share some of the most exciting developments in medicine.

A New Paradigm in Medicine: Understanding Regenerative Biologics

As a clinician who has dedicated my career to finding the most effective paths to healing, I am continually inspired by the advancements in regenerative medicine. I recently had the privilege of listening to one of the field’s true pioneers, Dr. John Skaravakis, a distinguished medical doctor who specializes in physical medicine, rehabilitation, and sports injuries. His journey mirrors that of many of us in integrative and functional medicine—a journey born from a frustration with the limitations of conventional treatments.

Like Dr. Skaravakis, I grew tired of the traditional playbook for chronic injuries: first, physical therapy; next, anti-inflammatory drugs (NSAIDs); then, corticosteroid injections; and finally, the often-dreaded recommendation for surgery. This approach frequently felt like a cycle of managing symptoms rather than resolving the underlying problem. Patients would find temporary relief, but they rarely returned to their pre-injury level of function. The core issue—the body’s diminished or broken healing capacity—was never truly addressed. This frustration is what propelled me, and colleagues like Dr. Skaravakis, toward regenerative medicine, a field that seeks to work with the body’s innate intelligence to repair and rebuild.

In my own practice, this shift has been transformative. By combining chiropractic principles—which focus on optimizing the body’s structure and nerve function—with the cellular-level repair offered by regenerative medicine, we can create a powerful synergy for healing.

The Fundamental Question: Why Do We Hurt?

To appreciate the power of regenerative medicine, we must first understand why chronic pain persists. Dr. Skaravakis eloquently breaks it down into a few key factors: a broken healing cycle, chemical irritation, chronic mechanical stress, and nerve injury.

When we are young, our bodies are healing powerhouses. Think of a child who scrapes a knee; within days, the wound is a distant memory. This rapid repair is due to a rich supply of specialized cells, including pericytes—stem cells that reside near our blood vessels, ready to spring into action at the first sign of injury. Dr. Arnold Caplan, a seminal figure in stem cell research, famously illustrated the dramatic decline of these cells with age. A newborn has approximately one stem cell for every 10,000 cells. By the time we reach our 50s, that ratio plummets to one in 400,000, and by our 80s, it’s a staggering one in two million.

This biological reality is at the heart of chronic pain. The constant battle between breakdown and repair eventually tilts in favor of breakdown. Our bodies can’t keep up. This is where modern medicine has often fallen short. The reliance on NSAIDs and steroids is a perfect example. While these drugs can be invaluable for acute, severe inflammation (such as a debilitating lumbar radiculitis where an epidural is needed for immediate relief), their long-term use is problematic. They act by masking the symptoms, effectively silencing the body’s alarm signals without fixing the fire. Worse, they can actively hinder the healing process and come with a host of systemic side effects.

This is why my chiropractic colleagues and I resonate so deeply with the principles of functional and regenerative medicine. We understand that pain is a signal, not the primary enemy. Our goal is to address the source of that signal.

Tissue Engineering: Restoring the Body’s Blueprint for Healing

So, how do natural biologics, or what we often refer to as Human Cell and Tissue Products (HCT/Ps), work? The concept is rooted in tissue engineering: the process of using cells, engineering principles, and biological factors to restore, maintain, or improve tissue function.

When we introduce these biologics into a damaged joint or tissue, they initiate a sophisticated, multi-step healing cascade:

1. Reduce Inflammation: The first and most immediate effect is a powerful anti-inflammatory response. These products contain molecules that down-regulate inflammatory cytokines, the chemical messengers that drive pain and swelling. This is why patients often report feeling significantly better within weeks, long before true structural repair has occurred.
2. Immunomodulation: This is a crucial, often overlooked effect. Regenerative biologics reprogram the local immune system. Instead of being stuck in a chronic, self-destructive inflammatory state, the immune response is modulated to support healing and regeneration. It tells the body, “Stop attacking yourself and start rebuilding.”
3. Calm Irritated Nerves: Chronic pain involves hypersensitive, “angry” nerves. Components within these biologics, similar in effect to natural agents used in prolotherapy like Sarapin (a pitcher plant extract), help to soothe these nerves, providing further pain relief and creating a more favorable environment for healing.
4. Signal for Regeneration: This is the most profound function. These cells act as “job foremen” or “conductors of an orchestra.” They don’t necessarily turn into new cartilage or tendon cells themselves in large numbers. Instead, they release a powerful cocktail of signaling molecules—a process known as the paracrine effect—that creates a “homing signal.” This signal calls upon the body’s own resident stem cells from fat, bone marrow, and other tissues to migrate to the site of injury, proliferate (multiply), and differentiate (specialize) into the exact tissue type that is needed.

It’s vital to understand this process takes time. The initial pain relief from the anti-inflammatory effect is quick, but the actual tissue remodeling—where new collagen fibers are laid down, vascularized, and strengthened—can take many months. As a clinician, it’s my job to manage patient expectations. When a patient with a knee that’s been degenerating for a decade feels incredible after three weeks, my response is always, “That’s fantastic! Now, let’s be smart. Don’t break your stitches.” We must respect the biology of healing.

Decoding the Power of Adult Mesenchymal Stem Cells

A frequent question is the source of the cells we use. There are various types, but my clinical focus and preference are firmly on adult mesenchymal stem cells (MSCs), specifically those derived from Wharton’s jelly, found in the umbilical cord.

You might have heard about embryonic stem cells, but I find they don’t perform as effectively in the clinical applications we focus on. I often use the analogy that they’re like a new employee who shows up but doesn’t quite produce the expected results. While there may be religious or personal beliefs that guide some individuals toward other options, and while a young, healthy athlete in their early twenties might have a robust supply of their own stem cells (autologous), the non-embryonic, adult MSC approach is, in my experience, a more direct and faster-acting path for most people seeking regenerative treatment.

I’ve had conversations with some of the brightest minds in this field, including Dr. Podmanis in Holland, a professor at the University of Tampa and a true pioneer who develops our cell lines. When I face a question I can’t answer, I defer to his expertise. He is currently developing specialized cell lines for experimental purposes, such as cells designed to support the substantia nigra in the brain to produce more dopamine for conditions like Parkinson’s. His work is so advanced that he can differentiate cells, programming them to become knee cartilage cells or hip cartilage cells. It’s truly amazing.

A critical point of assurance for patients is safety. We’ve both discussed this with experts, and I have never encountered a case where Wharton’s jelly-derived MSCs have become tumorigenic (cancer-causing). While there have been exceedingly rare reports of issues with some cord blood products administered intravenously, the cells we use do not replace entire organs and are not genetically altered.

The Power of Youth: Why Umbilical Cord Tissue Is a Preferred Source

When considering regenerative therapies, a common question arises: “Why not use my own cells?” This refers to autologous procedures using bone marrow aspirate concentrate (BMAC) or adipose (fat) tissue. While these can be effective, there are compelling reasons why many leading practitioners, including myself, often prefer allogeneic (donor) biologics derived from umbilical cord tissue.

As Dr. Skaravakis points out, there are two primary drawbacks to using your own aged cells.

1. Invasiveness and Risk: Harvesting bone marrow involves driving a large needle called a trocar into the iliac crest of the pelvis. It is an uncomfortable procedure with risks of significant pain, bruising, and, though rare, a deep infection (osteomyelitis). Adipose harvesting is a form of liposuction, which is also invasive.
2. The Age Factor: This is the most critical point. If you are 60 years old, you have 60-year-old stem cells. As Dr. Caplan’s research shows, these cells are far fewer in number and, for lack of a better term, “lazier” and less potent than their younger counterparts.

In contrast, biologics derived from the umbilical cord, which is collected after a healthy, full-term birth with full maternal consent, offer significant advantages:

• Youth and Potency: These are day-one, epigenetically pristine cells. They contain a dense concentration of live mesenchymal stem cells (MSCs), growth factors, cytokines, hyaluronic acid, and other regenerative components.
• Non-Invasive for the Patient: The product is ready to use, eliminating the need for a painful and risky harvesting procedure.
• Ethically Sourced: It’s crucial to clarify for patients that this is not fetal tissue. The umbilical cord and placenta, once considered medical waste, are now recognized as a “gold mine” of healing potential. The donation process poses absolutely no harm to the mother or child.

These products are a rich source of essential building blocks:

• Growth Factors: Proteins that stimulate cell growth, proliferation, and differentiation.
• Peptides and Carbohydrates: Provide energy and structural components.
• Messenger RNA (mRNA): Carries the genetic blueprint from DNA, instructing the regenerating cells on what type of tissue to build.
• Hyaluronic Acid (HA): A natural lubricant and shock absorber found in healthy joints. The HA in umbilical cord tissue is often more potent than the synthetic versions used in viscosupplementation (e.g., Supartz, Euflexxa). It provides immediate cushioning and stimulates the joint’s own synovial cells to produce more HA.

These cells are often referred to as Mesenchymal Signaling Cells because their primary role is to signal and orchestrate the body’s own healing response. They are the ultimate conductors, directing a symphony of cellular repair.

Addressing Common Patient Concerns: Safety and Purity

In today’s world, patients are more informed and rightly concerned about what is being introduced into their bodies. Two questions come up constantly:

1. Do these cells contain the spike protein from recent viruses?
2. Are there nanoparticles present?

The answer is a definitive no. I have not seen a single case where this was a concern. I posed this very question to another expert, Dr. Popov, who explained the elegant biology of the placenta. The placenta has two distinct sides: a maternal side and a fetal side. Crucially, there are protected areas where blood and other substances do not mix. Dr. Popov explained, “Nanoparticles are ten to the minus nine meters—incredibly small. We have tried to insert antibodies, which are as small as ten to the minus eighteenth, into the uterus, and they will not pass through the placental barrier.” This demonstrates the highly privileged and protected nature of the umbilical cord environment, ensuring the purity and safety of the cells we derive from it.

The Cellular Mechanics of Healing: How MSCs Work

To appreciate why these therapies are so effective, we need to understand their fundamental mechanisms of action. MSCs are not just passive building blocks; they are active communicators and regulators within the body.

Cellular Fusion and Communication

One of the most remarkable ways MSCs work is through a process that resembles how bacteria exchange genetic information. They form what are called tunneling nanotubes (TNTs), microscopic bridges that connect them to other cells. These are akin to the “pili” seen in bacteria. Through these TNTs, MSCs can directly exchange vital information, including proteins, lipids, and genetic material, with damaged or aging cells. They can also be absorbed directly into cells, delivering their therapeutic cargo where it’s needed most.

The Role of Growth Factors

A significant part of this cargo consists of powerful growth factors. These are proteins that stimulate cellular growth, proliferation, and differentiation. Some of the key players include:

• Vascular Endothelial Growth Factor (VEGF): This is crucial for angiogenesis, the formation of new blood vessels. This is particularly important for tissues with poor inherent blood supply, such as ligaments, tendons, and joint cartilage. In our late childhood and early teens, the rich blood supply to these tissues diminishes, and what we have left is what we must work with for the rest of our lives. This is why a muscle strain, which occurs in highly vascular tissue, often heals well, but a small tear in your knee meniscus can become a chronic, lifelong problem. By promoting new blood vessel growth, VEGF helps deliver oxygen and nutrients to these starved tissues, facilitating genuine repair.
• Platelet-Derived Growth Factor (PDGF): This growth factor also plays a vital role in cell growth and angiogenesis, contributing to the overall healing and regeneration of damaged tissues.

By introducing these growth factors into a joint or tissue, we are essentially re-establishing the biological processes that were active when we were younger and healed more efficiently.

Restoring Cellular Homeostasis and Reducing Oxidative Stress

From a functional medicine perspective, we often trace nearly every chronic condition back to a single root problem: cellular dysfunction. This dysfunction is typically caused by either a deficiency of essential nutrients or an overload of toxicity. One of the primary drivers of this dysfunction is oxidative stress.

Oxidative stress occurs when there is an imbalance between free radicals (unstable molecules that damage cells) and antioxidants (molecules that neutralize them). In our modern world, we are bombarded with factors that dramatically increase this stress:

• Environmental Toxins: We are exposed to infinitely more toxins than our grandparents ever were—from pesticides in our food and chemicals in plastics to pollutants in the air and soil.
• Chronic Stress: The nature of our stress has changed. Our ancestors may have experienced physical stress from farm labor. Still, we face a relentless barrage of mental and emotional stressors: financial pressures, political polarization, and a constant stream of anxiety-inducing news.
• Lifestyle Factors: We stay awake longer, disrupting our natural circadian rhythms, and often consume processed foods that fuel inflammation.

MSCs are powerful agents in combating this cellular chaos. They work directly at the cellular level to reduce oxidative stress and restore homeostasis, or balance. Patients who receive an intravenous (IV) infusion of MSCs often report a profound sense of calm and well-being. I experienced this myself. During my own infusion, I watched my heart rate drop from my normal 78 beats per minute down to 49. The following day, I felt a wonderful and persistent sense of tranquility. This is the physiological effect of reducing systemic inflammation and oxidative stress at its source.

Secretomes and Exosomes: The Messengers of Regeneration

In the evolving lexicon of regenerative medicine, you will increasingly hear the terms secretome and exosome. It’s important to understand what they are and why they are so significant.

The word exosome comes from two Greek words meaning “outside the body” or “outside the ball.” It refers to tiny vesicles, or sacs, that are released by cells. If you were to conduct a literature search on exosomes, you might find a confusing array of information, because many different types of cells produce them, including tumor cells and cancer cells. It’s simply a term for a small outcropping of a cell membrane, typically ranging from 50 to 150 nanometers in size.

However, in the context of regenerative medicine, we are specifically interested in the exosomes that are part of the secretome of Mesenchymal Stem Cells. The secretome is the complete collection of molecules and vesicles secreted by MSCs—it’s their communication toolkit. These MSC-derived exosomes are not cells themselves; they are messaging particles that carry a powerful cargo of growth factors, lipids, and, most importantly, genetic material like messenger RNA (mRNA) and microRNA (miRNA).

The Power of MicroRNA in Pain and Inflammation Modulation

One of the most exciting components of the exosome payload is microRNA. For those unfamiliar, microRNA is a small, non-coding segment of RNA, typically only 9 to 15 base pairs long. For a long time, scientists considered this “junk RNA,” believing it was just filler in our genetic code. We now know that microRNA plays a profound regulatory role in gene expression.

When you inject exosomes into a joint or administer them intravenously, patients often report feeling better remarkably quickly. A primary reason for this is the action of microRNA.

Think about what happens when you have an injured knee or shoulder. Any movement or pressure on it causes pain. This pain is a protective signal from your body. It’s your body’s way of saying, “Stop! Leave this area alone. It needs time to heal.” The pain is generated by inflammatory messages circulating in the area. Our typical response is often to take painkillers and continue to strain the joint, which disrupts the healing process.

When your body produces these inflammatory signals, it’s following a specific genetic code. The microRNA contained within the exosomes we introduce can insert itself into this code. What happens next is brilliant. The insertion of this new, short piece of RNA disrupts the original inflammatory message. It’s like typing a website address into your browser, but you get distracted and hit a couple of extra keys before pressing enter. The browser responds with an error: “URL not recognized.” The original command is nullified.

In the same way, the microRNA creates a “junk code” that stops the production of inflammatory proteins. The inflammatory cascade is halted, and the pain subsides much more quickly. This allows the body to shift from a state of chronic defense to a state of active healing.

This is why, when I perform injections for joints, even if I am using live cells, I almost always add an exosome component. The combination delivers both the long-term regenerative potential of the cells and the immediate anti-inflammatory and pain-relieving benefits of the exosomes. People feel better, faster.

The Blood-Brain Barrier Advantage

Another significant advantage of exosomes is their ability to cross the blood-brain barrier (BBB). The BBB is a highly selective, semipermeable border of endothelial cells that prevents solutes in the circulating blood from non-selectively crossing into the extracellular fluid of the central nervous system (CNS). This barrier is essential for protecting the brain, but it also makes it notoriously difficult to deliver therapeutic agents to it.

While there are methods to help live cells cross the BBB, exosomes can pass through it with relative ease due to their minuscule size. This makes them an invaluable tool for addressing conditions related to the central nervous system, such as:

• Mild-onset vascular dementia
• Parkinson’s disease
• Post-concussion syndrome
• The neurological symptoms of “long COVID”

By starting with exosomes, we can deliver these powerful regenerative signals directly to the brain and spinal cord, opening up new avenues for treating some of the most challenging neurological conditions.

Clinical Applications: From Joints to Autoimmunity

The potential applications for MSCs and their secretomes are so vast that the question is almost, “What can’t you do with them?” However, it’s crucial to maintain a grounded, evidence-based perspective and not get “stars in your eyes,” thinking this is a panacea for every ailment. There are contraindications, and patient selection is key.

My personal journey in regenerative medicine began with musculoskeletal (MSK) and joint conditions, stemming from my background in sports medicine and chiropractic. From there, my focus expanded to include central nervous system issues like tremor and Parkinson’s, and then to the many autoimmune patients who come to my practice seeking relief.

Here are just a few examples of the conditions we address:

• Musculoskeletal (MSK) Health: This includes osteoarthritis, ligament and tendon tears, degenerative disc disease, and chronic joint pain. By injecting MSCs and exosomes directly into the affected area, we can reduce inflammation, modulate pain, and stimulate the regeneration of cartilage, ligaments, and other tissues.
• Autoimmune Diseases: Conditions like lupus (SLE), rheumatoid arthritis, and multiple sclerosis are characterized by a dysregulated immune system that attacks the body’s own tissues. MSCs are powerful immunomodulators. They don’t just suppress the immune system; they reprogram it, helping to restore balance and calm the autoimmune response. There are numerous articles on PubMed detailing the benefits of MSCs for conditions like SLE.
• Neurological Conditions: As mentioned, exosomes are particularly promising for CNS disorders. We have seen benefits in patients with mild cognitive decline, movement disorders, and the persistent neurological symptoms associated with long COVID, such as brain fog and headaches.
• Aesthetics and Skin Repair: While I initially didn’t focus on aesthetics, I have seen the remarkable benefits firsthand. My wife is an esthetician, and we’ve witnessed incredible results in her patients and my own family members. My sister, for instance, had a significant scar on her face from a dog bite she sustained as a child. Despite multiple surgeries over the years, the scar remained prominent. After injecting it with these biologics, I saw her two weeks later, and the scar tissue had shrunk dramatically. Today, it’s barely noticeable, and the overall quality of her skin has improved.

A Landmark Study on COVID-19

The power of MSCs was highlighted in a compelling study conducted at the University of Miami/Jackson Memorial Medical Center during the COVID-19 pandemic. The study focused on severely compromised COVID-19 patients, a very high-risk group with an average age of 75, many of whom were bed-dependent.

These patients received 200 million MSCs intravenously over three days. The results were staggering:

• Recovery Time: Over 50% of the treated patients were discharged from the hospital within two weeks.
• Survival Rate: At one month, the survival rate in the stem cell group was 91%, compared to just 42% in the control group.
• Overall Recovery: By day 30, 80% of the treatment group had recovered, compared to only 37% of the control group.
• Age-Related Outcomes: For patients under the age of 85 who received the treatment, the one-month survival rate was 100%.

This study provides powerful evidence that MSCs can modulate the severe inflammatory storm associated with critical illness and promote profound healing, even in the most vulnerable patients.

Treating Long COVID

We see many patients in our clinic suffering from long COVID. The symptoms are varied and can affect any part of the body. Still, the most common complaints I encounter are respiratory issues, debilitating brain fog, memory problems, headaches, and even infertility.

Patients with reactive airway disease post-COVID often do beautifully with this therapy. Their pulmonary tests might look normal, but they are dealing with a persistent inflammatory process. We can administer the therapy intravenously, through a nebulizer for direct lung delivery, or even with a specialized device called the Curbay, which can deliver the biologics directly to the cribriform plate area near the olfactory nerve, providing a more direct route to the central nervous system.

The Untapped Power of Your Period: A New Frontier in Regenerative Medicine

The journey into understanding the power of cellular therapies has recently led to a discovery that is both profoundly elegant and surprisingly recent. As I delve into the latest research presented by brilliant minds like Dr. Michelle Ferguson, an MD who transitioned from intensive care to women’s health and longevity, I am consistently reminded of the human body’s incredible capacity for self-renewal. Dr. Ferguson’s work highlights a biological marvel that has been overlooked for far too long: the regenerative power of the uterus.

For approximately 40 years of a woman’s life, her body orchestrates a feat of regenerative biology that we, with all our advanced technology, cannot replicate in any laboratory on Earth. Each month, an entire tissue bed—the endometrium—is meticulously constructed, shed during menstruation, and, remarkably, rebuilt from the ground up, all without scarring.

A Holy Grail in Plain Sight

Think about the implications. If a cardiologist could induce heart muscle to regenerate this completely and without scarring after a heart attack, it would revolutionize cardiovascular medicine. This concept of complete, repeatable, and scar-free regeneration is, in many ways, the holy grail of regenerative medicine. And yet, this exact process has been occurring naturally, every month, in half of the human population. Menstrual blood is not waste but a rich, non-invasive source of some of the most potent regenerative cells in the human body.

A New Era of Cell Science: The Discovery of Menstrual Stem Cells

The field is barely two decades old, which places us at the very beginning of a new and exciting frontier.

• 2007: The Initial Discovery: Researchers Meng et al. made a pivotal discovery. They successfully isolated a unique population of stem cells from menstrual blood, which they named Endometrial Regenerative Cells (ERCs) (Meng, X. et al., 2007).
• 2008: Characterization and Naming: The following year, a team led by Patel et al. further characterized these cells, giving them the name that is widely used today: Menstrual Stem Cells (MSCs) (Patel, A. N., et al., 2008).

The Unique Potency of Menstrual Stem Cells

What makes these cells so special? On paper, menstrual stem cells are classified as mesenchymal stem cells (MSCs), but they appear to be a uniquely potent and evolutionarily optimized version.

• Rapid Proliferation: Menstrual stem cells have a doubling time of under 20 hours, compared to bone marrow MSCs, which take closer to 48 hours. This means a large number of therapeutic cells can be generated from a small initial sample, very quickly.
• Genomic Stability: They maintain this rapid division while keeping a stable set of chromosomes (a normal karyotype) through dozens of divisions, a critical safety feature.
• Youthful Molecular Signature: These adult cells retain the active genetic “software” of younger cells, expressing pluripotency markers like OCT4 and active telomerase, which fends off cellular aging.
• No Teratoma Risk: Crucially, while they possess features of pluripotency, they do not carry the risk of forming teratomas (tumors), a known risk with embryonic stem cells.

The Secretome: A Paradigm Shift to “Cells as Factories”

One of the most significant shifts in MSC therapy has been understanding how these cells work. The old “cells as bricks” model, where stem cells were thought to rebuild tissue physically, has been replaced by the “cells as factories” model. The therapeutic benefit comes from the paracrine effect, where the stem cell acts as a “general contractor,” releasing a powerful cocktail of signaling molecules—the secretome—that instructs local cells to repair.

This secretome includes growth factors, immunomodulatory cytokines, and extracellular vesicles (EVs) like exosomes, which deliver new instructions directly into target cells.

The Uniquely Antifibrotic Secretome of Menstrual Stem Cells

Fibrosis, or scarring, is wound healing that fails to stop. It is a relentless process where functional tissue is replaced by stiff, non-functional scar tissue, contributing to as much as 35% of all mortality in the developed world. It is a vicious, self-sustaining loop where stiffness begets more stiffness.

The endometrium is a biological marvel because it is intrinsically antifibrotic. It undergoes a monthly cycle of inflammation, wounding, and matrix breakdown—all classic triggers for fibrosis—yet it heals without scarring. The secretome of menstrual stem cells is naturally engineered to promote this scarless healing.

• TGF-? Ratio: It contains high levels of antifibrotic TGF-?3 relative to pro-fibrotic TGF-?1.
• Antifibrotic Signals: It is rich in Hepatocyte Growth Factor (HGF) and matrix-remodeling enzymes like MMP-3, which actively break down scar tissue.
• Immunomodulation: It contains signals like Interleukin-10 (IL-10) that switch the immune response from inflammatory (M1 macrophages) to healing (M2 macrophages).

This powerful, coordinated antifibrotic and anti-inflammatory program is what makes the secretome of menstrual stem cells so promising for a wide range of conditions.

Human Evidence for Regeneration

The most compelling evidence for the power of menstrual stem cells comes from clinical trials in women with Asherman’s syndrome, a severe form of uterine scarring causing infertility.

• In two independent studies (Tan et al., 2021 and Ma et al., 2020), autologous menstrual stem cells were transferred into the uterus of women who had failed all other treatments.
• Results: In both studies, endometrial thickness doubled to a viable level, and a remarkable 43% of these previously infertile women went on to conceive naturally. This is powerful, in-human evidence of true tissue regeneration.

The potential extends far beyond the uterus. Early studies have shown promising results in:

• Premature Ovarian Failure: Over a third of women treated achieved pregnancy.
• Acute Respiratory Distress Syndrome (ARDS): A randomized, placebo-controlled trial using the cell-free menstrual stem cell secretome showed a survival rate of 57% versus 28% in the control group, with a 77% reduction in the inflammatory marker CRP.
• Neurology: A safety trial in patients with Multiple Sclerosis (MS) showed no adverse effects with direct intrathecal administration.
• Wound Repair: An ex vivo human skin model showed 100% wound closure at 24 hours with the menstrual fluid secretome, compared to just 40% with plasma. A murine study by Cuenca et al. (2018) found that menstrual MSCs expressed genes for key repair proteins like elastin (13x more), MMP-3 (22x more), and PDGF (800x more) compared to umbilical cord MSCs, leading to faster healing and better-organized collagen.

This science represents a paradigm shift. We are harnessing a biological program perfected over millennia for one purpose: scarless, functional regeneration.

Unlocking Pelvic Floor Health: Beyond Kegels with HIFEM Technology

One of the most common yet seldom-discussed health issues affecting millions is pelvic floor dysfunction. This condition, often manifesting as urinary incontinence, is frequently dismissed as a normal part of aging or childbirth. The pelvic floor is a complex web of muscles providing critical support for our pelvic organs. When these muscles weaken, the consequences can be debilitating.

Urinary incontinence is not limited to a specific demographic; it affects postpartum women, athletes, men (especially post-prostatectomy), and the aging population. The traditional advice—Kegel exercises—is often ineffective due to flawed execution, insufficient intensity, and poor consistency.

A Technological Leap: High-Intensity Focused Electromagnetic (HIFEM) Therapy

This is where a revolutionary technology comes into play. High-Intensity Focused Electromagnetic (HIFEM) therapy uses a specialized chair that a patient sits on, fully clothed. The chair generates a focused electromagnetic field that induces thousands of supramaximal pelvic floor muscle contractions in a single 28-minute session—the equivalent of performing 11,000 perfect Kegels.

• Mechanism: The HIFEM energy bypasses the brain to stimulate motor neurons directly, engaging 100% of the muscle fibers. This intense workout triggers hypertrophy (growth of existing fibers) and hyperplasia (creation of new fibers), rebuilding muscle strength and restoring neuromuscular control.
• The Protocol: A typical treatment involves six sessions over three weeks. The results are often transformative. Patients report a dramatic reduction or complete elimination of urinary leakage, regaining confidence and quality of life.

Integrating Pelvic Floor Therapy with Chiropractic Care

In our clinic, this advanced therapy is integrated into a holistic care plan that includes chiropractic adjustments. The connection is the nervous system.

• The nerves that control the pelvic floor muscles (primarily the pudendal nerve) originate from the sacral plexus (S2-S4). Misalignments in the lumbar spine or sacroiliac joints can irritate these nerves, disrupting signals to the pelvic floor.
• As a chiropractor, I restore proper joint motion and decompress nerve roots, ensuring the brain’s commands reach the pelvic floor muscles clearly.
• A weak pelvic floor creates an unstable base for the spine. By strengthening the pelvic floor with HIFEM, we make chiropractic adjustments more effective and longer-lasting.

By combining HIFEM therapy to rebuild the muscles with chiropractic care to optimize the nerve supply, we address the problem from two critical angles, creating a more robust and lasting solution.

The Unseen Enemy: Unmasking and Managing Chronic Allergies

We now shift to another pervasive condition: allergies. Most people associate allergies with seasonal sneezing, but the modern, evidence-based understanding reveals a far more complex and systemic picture. Allergies are a significant driver of chronic inflammation that can contribute to a vast array of health problems, including:

• Migraines and Chronic Headaches
• Neurological Issues (e.g., brain fog, fatigue, and even tics)
• Chronic Sinusitis

The reality is that more than 50% of the patient population likely has underlying allergies contributing to their chronic health complaints.

A Turnkey Solution for In-Office Allergy Testing and Treatment

Our clinic has adopted a comprehensive, turnkey allergy program that allows us to identify and treat a wide range of environmental allergens efficiently.

• The Testing Process: The gold standard of percutaneous skin testing (scratch test) is quick (15-20 minutes), safe, and efficient. A trained staff member applies small amounts of allergen extracts to the skin. If an allergy is present, a localized “wheal and flare” reaction occurs. Results are immediate. The test is covered by approximately 90% of insurance plans, making it a clinically and financially viable service.
• Beyond Identification: The Power of Immunotherapy: The long-term solution is immunotherapy, a treatment that retrains the immune system to tolerate allergens.

1. Subcutaneous Immunotherapy (SCIT): Traditional “allergy shots” require weekly office visits, which fits well into a chiropractic practice where patients are accustomed to regular visits.
2. Sublingual Immunotherapy (SLIT): A modern, patient-friendly alternative. The allergen extract is formulated into drops that the patient administers under their tongue at home daily. SLIT is incredibly safe, convenient, and dramatically improves patient compliance.

Both SCIT and SLIT are three-to-five-year treatment plans, representing a long-term commitment to care that induces lasting immunological change.

The Integrative Synergy: Chiropractic Care and Allergy Management

How does allergy management fit into a practice focused on musculoskeletal health? The connection is inflammation.

• Increased Pain Sensitivity: Systemic inflammation from allergies can make nerves more sensitive, amplifying pain signals from conditions like arthritis or disc herniations.
• Impaired Healing: Inflammation impedes the body’s ability to repair damaged tissues, slowing recovery from injuries.
• Affects Posture: Chronic sinus congestion can lead to forward head posture, placing strain on the neck and upper back.

By integrating allergy testing and treatment, we add a powerful tool for reducing a patient’s total inflammatory load. When we use chiropractic adjustments to reduce biomechanical stress and simultaneously use immunotherapy to calm the immune system, we create a powerful synergistic effect that leads to faster, more complete, and more lasting results.

The Importance of the “Soil”: Creating a Healing Environment

I cannot overstate this principle: environment is everything. You can inject the highest quality regenerative products in the world, but if you plant them in toxic “soil,” they will not thrive. Before administering these powerful therapies, I have a “come to Jesus” talk with my patients. We must first address the “fires” in their system. This includes:

• Metabolic Health: If a patient’s A1c is 15 and their diet consists of fast food, we have to address that first.
• Toxicity: If they have mold toxicity, heavy metal exposure, or other significant toxic burdens, we need to implement a detoxification plan.
• Lifestyle Factors: Smoking, excessive alcohol consumption, and chronic lack of sleep all create a pro-inflammatory environment that will sabotage the treatment.

We do a thorough workup, which may include comprehensive lab work, to identify these underlying issues. By getting the patient healthier before the procedure, we create an environment where the MSCs can do their best work. The results will be exponentially better.

From Conversation to Care Plan: How Real-Life Encounters Shape Clinical Priorities

In my practice, clinical care begins with connection. Casual conversations about families, careers, and daily life reveal stressors, sleep disruptions, and physical deconditioning patterns that link directly to symptoms. I am a hugger—and I say that with a smile—because connection lowers sympathetic tone. The nervous system notices safety. Trust helps patients tell me where they actually hurt, how symptoms flare with stress, or how a minor fall never quite resolved. In personal injury cases, these snippets are vital for our documentation and guide a targeted, ethical plan.

I meticulously review PI files because detailed records help us advocate for appropriate care and counteract the common minimization of soft tissue injuries. The most powerful argument is precise documentation tethered to anatomy, physiology, and function—with outcomes tracked over time. This real-world experience, combined with the latest science, shapes the evidence-based, patient-centered protocols we use every day. We believe that when doctors become certain—grounded in science and aligned with patient values—patients become certain too. That certainty becomes the foundation for adherence, better outcomes, and renewed Trust.

Practical Guidelines and Protocols: The Art and Science of Administration

In a busy clinical setting, having clear, evidence-based protocols is essential for delivering safe and effective care. This applies to everything from manual therapies to advanced regenerative procedures.

A Practitioner’s Guide to Musculoskeletal (MSK) Injections

For MSK conditions, which are a common entry point into regenerative medicine, I follow a set of guiding principles:

1. A Thorough History and Physical Exam (H&P) is Non-Negotiable: My father, a brilliant cardiologist, gave me his greatest advice: “If you listen to the patient, you’ll get the diagnosis nine times out of ten.” It is essential to listen to their story, ask the right questions, and then perform a comprehensive physical exam.
2. The Power of a Report of Findings (ROF): We take the time to synthesize findings and present a clear plan. Explaining why a treatment is right for them builds Trust and ensures the patient is an active participant.
3. “This is My MRI”: The Reproducibility Instrument: Ross Hauser, a pioneer in prolotherapy, calls his fingers his “MRI,” or “My Reproducibility Instrument.” If I can press on a specific spot and reproduce the exact discomfort the patient experiences, that is very likely where the problem lies. Trust your hands and the patient’s feedback.
4. Look for Laxity and Instability: A key concept championed by George Hackett, MD, is that “A joint is only as strong as its weakest ligament.” Ligamentous laxity leads to joint instability, which creates abnormal shearing forces on the cartilage and can lead to arthritis. The solution is simple in concept: tighten it up. By injecting biologics into lax ligaments, we stimulate them to heal, tighten, and restore stability.

The Art of Administration: Best Practices for Procedure Day

The day of the procedure requires focus, preparation, and a calm demeanor. As Wyatt Earp supposedly said, “Last is fine, but accuracy is final.”

• Preparation: The patient should be on the table, comfortable, and consented before the product is thawed.
• Product Handling: My friend, Dr. Joe Raj, has a mantra I live by: “Make the patient wait for the product, don’t make the product wait for the patient.” Once thawed, I like to place the syringe under a red light therapy machine for a few minutes to “wake up” the cells.
• Creating a Calm Environment: You are the captain of the ship. Project calm and confidence. I am blessed to have an amazing medical assistant whose unflappable demeanor is incredibly reassuring to patients. A calming presence is key.
• Patient Pre-Procedure Instructions: I tell patients to get a good night’s sleep and hydrate well. If someone comes in exhausted and nervous, I would rather reschedule to ensure the best possible experience and outcome.

The Cabinet Hinge Analogy: Understanding Joint Derangement

To help patients visualize joint instability, I use the analogy of a kitchen cabinet door. The screws are the ligaments, the hinges are the joint capsule, the door is the bone, and paint chipping is cartilage degeneration (arthritis). The conventional approach is to wait until the door falls off and then replace it (joint replacement surgery). Our regenerative approach is to intervene when the screws are loose. We go in and tighten the hinges, reinforcing the original structure by injecting proliferative solutions into the lax ligaments and joint capsule.

Clinical Certainty And Communication: The Foundation of Trust

In my experience, patients do not fear buying care—they fear uncertainty. When doctors become certain, patients become certain. This certainty is not arrogance; it’s clarity rooted in evidence and empathy. I learned to talk less and ask more questions, focusing on the why behind the pain. This approach dramatically improved my case acceptance and long-term outcomes. We offer clear choices:

• Acute Care Option: For short-term relief.
• Long-Term Solution Option: A phased plan for durable correction and prevention.

When patients see the rationale and have control, they often choose the plan that resolves the problem, not just the symptom. This ethical transparency feels better for everyone. Patients feel respected, clinicians feel aligned with their purpose, and the clinic remains sustainable to serve more people.

Conclusion: The Future is Integrative, Collaborative, and Evidence-Based

The human body possesses a profound and innate capacity for healing. The science of regenerative medicine, particularly the study of cellular secretomes, is not creating new biology but rather learning to read and apply the regenerative symphony that nature has already perfected. From the scarless healing of the endometrium to the complex signaling of mesenchymal stem cells, we are uncovering powerful, multi-pronged therapeutic programs that can modulate inflammation, combat fibrosis, and stimulate true tissue repair.

In our practice at Injury Medical Clinic, this cutting-edge science is not an isolated service. It is woven into a comprehensive, integrative framework. Under the expert medical direction of Dr. Maria Guadalupe Cardenas, we combine these advanced therapies with the foundational principles of chiropractic care, functional medicine, and personalized rehabilitation. We optimize the body’s systemic environment by reducing inflammation, correcting structural misalignments, and providing the necessary nutritional support for cellular regeneration.

This fusion of disciplines allows us to move beyond simply managing symptoms and instead address the root causes of dysfunction. It is a model built on collaboration, evidence, and a deep respect for the body’s own healing intelligence. By integrating the best of modern science with time-tested principles of holistic care, we can offer our patients a clear, effective, and empowering path to not just get out of pain, but to get back to living their lives to the fullest. The future of medicine lies in this integration—blending the best of foundational care with the most promising innovations of biological science.

Disclaimer: The information in this post is for educational purposes only and is not intended as medical advice. The content reflects the views and clinical observations of Dr. Alex Jimenez and the insights from the work of respected researchers in the field. All medical decisions should be made in consultation with a qualified healthcare provider. Dr. Jimenez’s practice, Injury Medical Clinic PA, operates under the medical direction of Dr. Maria Guadalupe Cardenas, MD.

References

• Ajimsha, M. S., Al-Mudahka, N. R., & Al-Madzhar, J. A. (2015). Effectiveness of myofascial release: Systematic review of randomized controlled trials. Journal of Bodywork and Movement Therapies, 19(1), 102–112.
• Akhbari, B., et al. (2022). Safety and efficacy considerations in the clinical translation of extracellular vesicle-based therapeutics. Journal of Extracellular Vesicles.
• Aragón-Vela, J., et al. (2021). Efficacy of high-intensity focused electromagnetic therapy in the treatment of urinary incontinence: a systematic review. Actas Urológicas Españolas (English Edition), 45(6), 449-457.
• Bassett, S. F. (2015). The assessment of patient adherence to physiotherapy rehabilitation. New Zealand Journal of Physiotherapy, 43(3), 131–137.
• Basson, A., Olivier, B., Ellis, R., Coppieters, M. W., Stewart, A., & Mudzi, W. (2017). The effectiveness of neural mobilization for musculoskeletal conditions: A systematic review and meta-analysis. Journal of Orthopedic & Sports Physical Therapy, 47(9), 593–615.
• Bialosky, J. E., et al. (2018). Spinal manipulative therapy-specific changes in pain sensitivity: A systematic review and meta-analysis. Pain.
• Boden, S. D., Davis, D. O., Dina, T. S., Patel, M. R., & Wiesel, S. W. (1990). Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. The Journal of Bone and Joint Surgery, 72(3), 403–408.
• Brinjikji, W., Luetmer, P. H., Comstock, B., Bresnahan, B. W., Chen, L. E., Deyo, R. A., … & Jarvik, J. G. (2015). Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR American Journal of Neuroradiology, 36(4), 811–816.
• Butler, D. S., & Moseley, G. L. (2013). Explain Pain. Noigroup Publications.
• Calderón M. A., et al. (2015). Sublingual immunotherapy for allergic rhinitis: an updated Cochrane systematic review. Cochrane Database of Systematic Reviews, (9), CD011293.
• Chimutengwende-Gordon, M., et al. (2020). Decellularized scaffolds in tendon and ligament repair. Bone & Joint Research.
• Cuenca, J., Le-Gatt, A., Castillo, V., & Beltrán, F. A. (2018). The reparative activities of menstrual-versus-bone-marrow-derived-mesenchymal stem cells in a murine model of excisional-wounding. Frontiers in Physiology, 9, 1358.
• Di Lorenzo, G., et al. (2021). Sublingual immunotherapy: a review of the latest evidence. Expert Review of Clinical Immunology, 17(9), 923-936.
• Docheva, D., Müller, S. A., Majewski, M., & Evans, C. H. (2015). Biologics for tendon repair. Advanced Drug Delivery Reviews, 84, 222–239.
• Driscoll, T. P. (2018). Cellular orthopedic treatments. In T. P. Driscoll (Ed.), The regenerative medicine series: Cellular orthopedic treatments (pp. 1–25).
• Evans, C. F., Sgarioto, N., Rittenhouse, N. L., Singh, K., & Singh, G. (2019). The regenerative capacity of the menstrual-fluid-derived-mesenchymal-stromal-cell-secretome-on-human-skin-keratinocytes. International Journal of Molecular Sciences, 20(14), 3564.
• Everhart, J. S., Cavendish, P. A., & Flanigan, D. C. (2019). The efficacy of biologic augmentation for non-operative management of osteoarthritis and cartilage defects. Current Reviews in Musculoskeletal Medicine, 12(2), 176–183.
• (2023). Regulatory considerations for human cells, tissues, and cellular and tissue-based products (HCT/Ps).
• Finan, P. H., Goodin, B. R., & Smith, M. T. (2013). The association of sleep and pain: An update and a path forward. The Journal of Pain, 14(12), 1539–1552.
• Galipeau, J., & Sensébé, L. (2018). Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities. Cell Stem Cell, 22(6), 824–833.
• Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008). The development of allergic inflammation. Nature, 454(7203), 445-454.
• Gioxari, A., Kaliora, A. C., Marantidou, F., & Panagiotakos, D. P. (2018). Intake of omega-3 polyunsaturated fatty acids and improvement of inflammatory status in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized controlled trials. Nutrition, 55–56, 1–14.
• Guo, R., Li, L., & Li, M. Q. (2019). The role of food allergy in the pathogenesis of migraine. The Journal of Headache and Pain, 20(1), 77.
• Haack, M., Simpson, N., Sethna, N., Kaur, S., & Mullington, J. M. (2020). Sleep deficiency and chronic pain: Potential underlying mechanisms and clinical implications. Neuropsychopharmacology, 45(1), 205–216.
• Hackett, G. S. (1956). Ligament and tendon relaxation treated by prolotherapy. Charles C. Thomas.
• Hauser, R. A., Lackner, J. B., Steilen-Matias, D., & Harris, D. K. (2016). A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 9, 139–159.
• Hayden, J. A., Ellis, J., Ogilvie, R., Malmivaara, A., & van Tulder, M. W. (2021). Exercise therapy for chronic low back pain: A systematic review within the framework of the Cochrane Collaboration Back and Neck Group. Cochrane Database of Systematic Reviews, 2021(9), CD009790.
• Hotamisligil, G. S. (2017). Inflammation, metaflammation and immunometabolic disorders. Nature.
• Hsu, M. I., et al. (2022). A prospective, multicenter study on the efficacy of high-intensity focused electromagnetic therapy for the treatment of stress urinary incontinence. Taiwanese Journal of Obstetrics and Gynecology, 61(2), 292-297.
• Hyman, M. (2021). The Pegan Diet: 21 Practical Principles for Reclaiming Your Health in a Nutritionally Confusing World. Little, Brown Spark.
• International Society for Cell & Gene Therapy (ISCT). (2020). Statement on extracellular vesicle- and exosome-based therapeutics.
• Ioppolo, F., Tattoli, M., Di Sante, L., Venditto, T., Delicata, M., & De Santis, F. (2013). Clinical efficacy of radial ESWT in calcific tendinitis of the shoulder: Randomized controlled trial. European Journal of Physical and Rehabilitation Medicine, 49(2), 205–213.
• Jacob, C. I., Paskova, K., & Kinney, B. M. (2018). Histological and imaging studies on the effects of a novel high-intensity focused electromagnetic field (HIFEM) device on abdomen. Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS).
• Jarvik, J. G., & Deyo, R. A. (2002). Diagnostic evaluation of low back pain with emphasis on imaging. Annals of Internal Medicine, 137(7), 586–597.
• Keane, T. J., & Badylak, S. F. (2015). The host response to allogeneic and xenogeneic biological scaffold materials. Journal of Tissue Engineering and Regenerative Medicine.
• Keshtkar, S., Azarpira, N., & Ghahremani, M. H. (2018). Mesenchymal stem cell-derived exosomes: A new horizon in regenerative medicine. Stem Cell Research & Therapy, 9(1), 1–10.
• Khan, K. M., & Scott, A. (2009). Mechanotherapy: how physical therapists’ prescription of exercise promotes tissue repair. British Journal of Sports Medicine, 43(4), 247–252.
• Kjaer, M., Langberg, H., Heinemeier, K., Bayer, M. L., Hansen, M., Holm, L., … & Magnusson, S. P. (2009). From mechanical loading to collagen synthesis. Journal of Anatomy, 215(4), 448–457.
• Lanzoni, G., Linetsky, E., Correa, D., Messinger, C. A., Um-English, D., Suguihara, C., … & Ricordi, C. (2021). Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial. Stem Cells Translational Medicine, 10(5), 660–673.
• Lavagnino, M., et al. (2015). Mechanobiology of tendon. Journal of Orthopedic Research.
• Leal-Junior, E. C. P., Vanin, A. A., Miranda, E. F., de Carvalho, P. T. C., Dal Corso, S., & Bjordal, J. M. (2015). Effect of phototherapy (low-level laser therapy) on exercise performance and recovery: Systematic review and meta-analysis. Lasers in Medical Science, 30(2), 925–939.
• Lener, T., et al. (2015). Applying extracellular vesicles-based therapeutics in clinical trials. Journal of Extracellular Vesicles.
• Lin, S. Y., et al. (2018). Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA, 319(24), 2519-2529.
• Louw, A., Zimney, K., Puentedura, E. J., & Diener, I. (2016). The efficacy of pain neuroscience education on musculoskeletal pain: A systematic review. Physiotherapy Theory and Practice, 32(5), 332–355.
• Ma, H., Wu, Y., Zhang, W., Lu, C., Wang, J., & Wang, H. (2020). Efficacy of autologous-menstrual-blood-derived-stromal-cells for-the-treatment of-intrauterine-adhesions. Stem Cell Research & Therapy, 11(1), 1-11.
• Martínez-Segura, R., et al. (2012). Immediate sympathetic and parasympathetic responses after cervical manipulation. Manual Therapy.
• McKeon, P. O., & Hertel, J. (2008). Systematic review of postural control and lateral ankle instability. Journal of Athletic Training, 43(3), 305–315.
• Mellor, R., Grimaldi, A., Wajswelner, H., et al. (2018). Exercise and load management for gluteal tendinopathy: Randomized trial. BMJ, 361, k1662.
• Mendt, M., et al. (2019). Prospects of exosomes as a cell-free therapy. Frontiers in Immunology.
• Meng, X., Ichim, T. E., Zhong, J., Rogers, A., Yin, Z., Jackson, J., Wang, H., Ge, W., Bogin, V., Chan, K. W., Thé, G., Minev, B., & Riordan, N. H. (2007). Endometrial regenerative cells: a novel stem cell population. Journal of Translational Medicine, 5, 57.
• Mintken, P. E., et al. (2016). Clinical decision-making for shoulder pain: Thoracic manipulation and exercise. Journal of Orthopedic & Sports Physical Therapy, 46(2), 104–115.
• Moseley, G. L., & Butler, D. S. (2017). Explain Pain Supercharged: The Clinician’s Manual. Noigroup Publications.
• Paige, N. M., Miake-Lye, I. M., Booth, M. S., et al. (2017). Association of spinal manipulative therapy with clinical benefit and harm for acute low back pain. JAMA, 317(14), 1451–1460.
• Patel, A. N., Park, E., Kuzman, M., Benetti, F., Silva, F. J., & Allickson, J. G. (2008). Multipotent stem cells from the human menstrual blood of non-expectant women. Cell Transplantation, 17(3), 303–311.
• Pellati, A., et al. (2013). Effect of PEMF therapy on osteoarthritis: Clinical studies review. Rheumatology International, 33(3), 587–598.
• Phinney, D. G., & Pittenger, M. F. (2017). Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells, 35(4), 851–858.
• Rankin, G. (2020). The lifetime cost of osteoarthritis. National Institutes of Health. [Representative citation].
• Robbins, T., Diamandis, P. H., & Hariri, R. (2022). Lifeforce: How New Breakthroughs in Precision Medicine Can Transform the Quality of Your Life & Those You Love. Simon & Schuster.
• Rompe, J. D., et al. (2004). Repetitive low-energy shock wave therapy for chronic lateral epicondylitis. The American Journal of Sports Medicine, 32(3), 734–743.
• Rubinstein, S. M., de Zoete, A., van Middelkoop, M., et al. (2019). Spinal manipulative therapy for chronic low-back pain. The Cochrane Database of Systematic Reviews, 2019(9), CD013104.
• Samuels, J. B., et al. (2019). A prospective study on the efficacy of a high-intensity focused electromagnetic field (HIFEM) device for the treatment of urinary incontinence and for pelvic floor muscle strengthening. Urology, 134, 29-32.
• Saragiotto, B. T., Maher, C. G., Yamato, T. P., et al. (2016). Motor control exercise for chronic non-specific low-back pain. The Cochrane Database of Systematic Reviews, 2016(1), CD012004.
• Schleip, R., et al. (2012). Fascia can contract in a smooth muscle-like manner and thereby influence musculoskeletal mechanics. Medical Hypotheses.
• Schultz, K. F., & Dasa, V. (2021). The painful total knee arthroplasty: A clinical review. Ochsner Journal, 21(1), 77–86.
• Sciascia, A., & Cromwell, R. (2012). Kinetic chain rehabilitation: A theoretical framework. Athletic Training & Sports Health Care.
• Shaw, G., Lee-Barthel, A., Ross, M. L., Wang, B., & Baar, K. (2017). Vitamin C–enriched gelatin supplementation before intermittent activity augments collagen synthesis. The American Journal of Clinical Nutrition, 105(1), 136–143.
• Silantyeva, E., et al. (2021). A comparative study on the effects of a high-intensity focused electromagnetic procedure and Kegel exercises for the treatment of stress urinary incontinence. Lasers in Surgery and Medicine, 53(8), 1111-1117.
• Skou, S. T., Roos, E. M., Laursen, M. B., et al. (2018). A randomized, controlled trial of total knee replacement. NEJM, 373(17), 1597–1606.
• Sloan, M. (2019). Red Light Therapy: Miracle Medicine. Independently published.
• Speed, C. (2014). A systematic review of shockwave therapy in tendinopathies and plantar fasciitis. BMJ Open, 4(4), e004942.
• Tan, J., Li, P., Wang, Q., Li, Y., Li, X., Zhao, D., Xu, X., & Kong, L. (2021). Autologous-transplantation-of-menstrual-blood-derived-mesenchymal-progenitor-cells-for-endometrial-regeneration-in-patients-with-severe-asherman’s-syndrome. Human Reproduction, 36(10), 2723–2730.
• Thamsborg, G., et al. (2005). Treatment of knee osteoarthritis with a magnetic therapy device: Randomized, double-masked, placebo-controlled trial. Scandinavian Journal of Rheumatology, 34(4), 340–345.
• Theoharides, T. C., Stewart, J. M., Hatziagelaki, E., & Kolaitis, G. (2015). Brain”“fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin. Frontiers in Neuroscience, 9, 225.
• Thompson, J. A., O’Sullivan, P. B., Briffa, N. K., & Neumann, P. (2006). Differences in muscle activation patterns during pelvic floor muscle contraction and valsalva maneuver. Neurourology and Urodynamics, 25(2), 148-155.
• Turner, L. (2021). The US direct-to-consumer marketplace for unapproved stem cell interventions. Regenerative Medicine.
• Valdes, A. M., et al. (2018). Role of the gut microbiota in nutrition and health. BMJ.
• Vannini, F., Spalding, T., Andriolo, L., Berruto, M., D’Ayala, F., & Filardo, G. (2016). Sport and early osteoarthritis: The role of sport in etiology, progression and treatment of knee osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy, 24(6), 1786–1796.
• Vicenzino, B., et al. (2007). Manual therapy, exercise, and mobilization with movement in lateral epicondylalgia. Manual Therapy, 12(3), 200–211.
• Wang, J. H., et al. (2012). Mechanobiology of tendon. Journal of Biomechanics.
• Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014). The majestic role of mesenchymal stem cells in autoimmune diseases. Stem Cell Research & Therapy, 5(2), 1-8.
• Witwer, K. W., et al. (2019). Defining mesenchymal stromal cell-derived extracellular vesicles and their therapeutic use. Cytotherapy.
• Zhang, S., Wang, C., Li, F., & Wang, J. (2019). A-review-of-human-menstrual-blood-derived-stem-cells:-clinical-promise-and-potential-for-endometrial-regeneration. Stem Cell Research & Therapy, 10(1), 342.

SEO Tags:

Regenerative Medicine, Mesenchymal Stem Cells, Menstrual Stem Cells, Exosomes, Secretome, Dr. Alex Jimenez, Dr. Maria Cardenas, Integrative Chiropractic Care, Functional Medicine, El Paso TX, Fibrosis, Anti-Inflammatory, Tissue Regeneration, Scarless Healing, Pelvic Floor Dysfunction, Urinary Incontinence, HIFEM Therapy, Chronic Pain Treatment, Personal Injury Care, Musculoskeletal Health, Cellular Biology, Evidence-Based Medicine, Allergy Testing, Immunotherapy, SLIT, Long COVID, ARDS, Multiple Sclerosis, Joint Pain, Osteoarthritis, Biomechanics, Mechanotransduction, Patient Education, Multidisciplinary Clinic, Medical Director Internal Medicine, Pain Neuroscience Education, Spinal Manipulation, Rehabilitation Protocols, Sleep and Pain, Omega-3 Musculoskeletal, Return to Work Criteria, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic